United Therapeutics | UTHR - Zysk Z Działalności Operacyjnej

Cena Akcji
572.85
Dzienna Zmiana
3.74 0.66%
Miesięcznie
-2.64%
Rocznie
89.00%
Q2 Prognozy TE
555.02




Zysk Z Działalności Operacyjnej Zmiana Data
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 431K 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 514.3M 128.8M 2026-03
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.03B 2026-03
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -857M 597M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 758M 271M 2026-03
United Therapeutics USD -14.6M 403.9M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12